OptimizeRx CorporationOPRXNASDAQ
Loading
Gross Profit Growth TrendStable
Percentile Rank51
3Y CAGR-26.3%
5Y CAGR-21.4%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

3Y CAGR
-26.3%/yr
Quarterly compound
5Y CAGR
-21.4%/yr
Recent deceleration
Percentile
P51
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive growthStable
PeriodValue
Q4 202512.89%
Q3 2025-6.00%
Q2 202539.65%
Q1 2025-39.41%
Q4 202463.78%
Q3 202414.89%
Q2 2024-4.10%
Q1 2024-31.60%
Q4 202382.05%
Q3 202325.24%
Q2 20235.27%
Q1 2023-40.32%
Q4 202232.20%
Q3 20224.79%
Q2 202210.96%
Q1 2022-34.62%
Q4 202136.52%
Q3 202112.83%
Q2 202131.35%
Q1 2021-28.82%
Q4 202043.06%
Q3 202016.91%
Q2 202018.45%
Q1 2020-2.91%
Q4 201948.03%
Q3 2019-30.04%
Q2 201919.12%
Q1 2019-11.42%
Q4 201830.10%
Q3 20189.91%
Q2 201836.05%
Q1 2018-16.61%
Q4 201780.37%
Q3 201711.00%
Q2 201763.60%
Q1 2017-45.76%
Q4 201633.63%
Q3 20167.30%
Q2 201614.28%
Q1 2016-19.84%